Company Profile
Aditxt, Inc. Stock Price, News & Catalysts
- Ticker:
- ADTX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (-12.82%)
Close
Last updated: October 1, 2026
89.6K USD
Market cap
Why the stock is moving
As of Oct 1, 2026, ADTX closed down 12.8% at $0.0034. No new same-company headline was identified in the current news window.
Company overview
Immune Health Technology Company
Aditxt develops and assembles technologies for immune monitoring, immune modulation, and precision diagnostics. Its business is organized through subsidiaries and licensed platforms rather than a single therapeutic franchise.
Adimune Immune Modulation
Adimune holds rights to nucleic-acid-based technology intended to retrain immune responses. The platform is being explored for autoimmune and other immune-mediated diseases through preclinical and development programs.
AditxtScore Immune Monitoring
AditxtScore is designed to provide a personalized profile of immune status. The technology evaluates antibody and cellular responses and can support monitoring of infection, vaccination, and immune health.
Pearsanta Precision Diagnostics
Pearsanta is developing mitochondrial-DNA-based biomarkers for diseases including prostate cancer and endometriosis. Earlier discovery work has also identified potential biomarker signatures in additional cancers.
Subsidiary and Transaction Model
Aditxt forms or acquires subsidiaries around distinct technologies and seeks outside financing, partnerships, and acquisitions to expand them. This structure creates multiple development tracks but also makes execution dependent on transaction completion and capital availability.
Future catalysts
Recent news
- 01
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Aditxt, Inc. (ADTX)?
Aditxt, Inc. (ADTX) most recently closed at 0.00 USD, a -12.82% move versus the previous session.
What is the market cap of Aditxt, Inc. (ADTX)?
Aditxt, Inc. currently has a market capitalization of 89.6K USD on BioPharmSignal.
What does Aditxt, Inc. do?
Immune Health Technology Company Aditxt develops and assembles technologies for immune monitoring, immune modulation, and precision diagnostics. Its business is organized through subsidiaries and licensed platforms rather than a single therapeutic franchise. Adimune Immune Modulation Adimune holds rights to nucleic-acid-based technology intended to retrain...
On which exchange is ADTX stock listed?
Aditxt, Inc. (ADTX) is associated with NASDAQ, United States, Biopharma.
What is Immune?
Immune Health Technology Company Aditxt develops and assembles technologies for immune monitoring, immune modulation, and precision diagnostics.
Which conditions is Aditxt, Inc. targeting with Immune?
Aditxt, Inc. is associated with cancer therapeutics based on its company overview and current catalyst commentary.
What is Health?
Immune Health Technology Company Aditxt develops and assembles technologies for immune monitoring, immune modulation, and precision diagnostics.
What is Technology?
Immune Health Technology Company Aditxt develops and assembles technologies for immune monitoring, immune modulation, and precision diagnostics.